Article info

Download PDFPDF

Short report
TRPA1 expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes: TRPA1 as a novel factor and drug target in arthritis

Authors

  • Elina Nummenmaa The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland PubMed articlesGoogle scholar articles
  • Mari Hämäläinen The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland PubMed articlesGoogle scholar articles
  • Lauri J Moilanen The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland PubMed articlesGoogle scholar articles
  • Teemu Moilanen The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, FinlandCoxa Hospital for Joint Replacement, Tampere, Finland PubMed articlesGoogle scholar articles
  • Katriina Vuolteenaho The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland PubMed articlesGoogle scholar articles
  • Eeva Moilanen The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Eeva Moilanen; eeva.moilanen{at}uta.fi
View Full Text

Citation

Nummenmaa E, Hämäläinen M, Moilanen LJ, et al
TRPA1 expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes: TRPA1 as a novel factor and drug target in arthritis

Publication history

  • Received August 10, 2017
  • Accepted August 14, 2017
  • First published September 4, 2017.
Online issue publication 
September 04, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.